|
发表于 2023-2-17 15:14:58
|
显示全部楼层
Accordingly, it is also a possibility that activation of the mTOR pathway might take place in NPC cells after BALF3 expression, in addition to low dose DNA damage, which lead to tumor progression <a href=http://nolvadex.best>nolvadex d</a> At the same time, AIs often fail to reduce proliferation in ER positive HER2 positive breast cancers even amongst those that display a clinical response 41, 43; this suggests that growth factors other than oestrogen are driving proliferation, limiting the benefits of AIs in HER2 overexpressing tumours this observation would also account for the poorer long term outcomes in HER2 overexpressing breast cancer as reported in adjuvant trials with AIs 44, 45 |
|